Avantor Q4 organic growth 1%, adjusted EPS $0.27; full-year adjusted EPS $0.99

Avantor, Inc.

2024-FY EPS reported $1.04 revenue$6,783,600,000

Q4 net sales $1.69B, down 2% reported; organic growth 1% with bioprocessing up high-single digits.
Q4 GAAP EPS $0.73 (net income $500.4M); adjusted EPS $0.27; adjusted EBITDA margin 18.2%.
Full-year net sales $6.78B, down 3% reported; organic decline 2%; adjusted EBITDA $1.20B margin 17.7%.
Free cash flow Q4 $222.1M; full-year $768.3M; adjusted net leverage 3.2x as of Dec 31, 2024.
Bioscience Production segment Q4 net sales up 4% organic; Laboratory Solutions down 1% organic.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.